John Brenner Levine, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Social Isolation | 5 | 2012 | 367 | 1.420 |
Why?
|
| Genes, Immediate-Early | 2 | 2007 | 101 | 0.580 |
Why?
|
| Wound Healing | 3 | 2011 | 2776 | 0.480 |
Why?
|
| Housing, Animal | 1 | 2011 | 48 | 0.400 |
Why?
|
| Relaxation Therapy | 1 | 2011 | 178 | 0.370 |
Why?
|
| Autistic Disorder | 2 | 2011 | 1162 | 0.360 |
Why?
|
| Prefrontal Cortex | 4 | 2011 | 2147 | 0.350 |
Why?
|
| Yoga | 1 | 2011 | 252 | 0.310 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2007 | 32 | 0.300 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 607 | 0.280 |
Why?
|
| Thalamus | 1 | 2012 | 1023 | 0.280 |
Why?
|
| Child Behavior | 1 | 2011 | 831 | 0.260 |
Why?
|
| Environment | 1 | 2011 | 1121 | 0.260 |
Why?
|
| Oxytocin | 1 | 2009 | 394 | 0.250 |
Why?
|
| Locomotion | 1 | 2007 | 378 | 0.240 |
Why?
|
| Individuation | 2 | 1994 | 23 | 0.240 |
Why?
|
| Behavior, Animal | 2 | 2009 | 1880 | 0.230 |
Why?
|
| Dystonia | 1 | 2007 | 363 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2012 | 8300 | 0.220 |
Why?
|
| Antipsychotic Agents | 2 | 2007 | 3057 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2008 | 1395 | 0.200 |
Why?
|
| Functional Laterality | 1 | 2008 | 2280 | 0.200 |
Why?
|
| Hippocampus | 2 | 2012 | 3672 | 0.180 |
Why?
|
| Social Environment | 3 | 2011 | 1022 | 0.180 |
Why?
|
| Clozapine | 1 | 2003 | 498 | 0.180 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1148 | 0.160 |
Why?
|
| Oocytes | 1 | 2003 | 1186 | 0.160 |
Why?
|
| Rats | 8 | 2012 | 24250 | 0.160 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2003 | 896 | 0.160 |
Why?
|
| Motor Activity | 1 | 2007 | 2714 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2012 | 6622 | 0.140 |
Why?
|
| MMPI | 5 | 1987 | 86 | 0.140 |
Why?
|
| Animals, Newborn | 3 | 2012 | 2725 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3622 | 0.130 |
Why?
|
| Nerve Degeneration | 1 | 1999 | 748 | 0.130 |
Why?
|
| Motor Neurons | 1 | 1999 | 841 | 0.120 |
Why?
|
| Personality Tests | 1 | 1994 | 83 | 0.120 |
Why?
|
| Dementia | 1 | 2008 | 2518 | 0.120 |
Why?
|
| Personality Inventory | 3 | 1993 | 1030 | 0.120 |
Why?
|
| Anxiety, Separation | 1 | 1994 | 86 | 0.120 |
Why?
|
| Depression | 2 | 2008 | 7760 | 0.120 |
Why?
|
| Personality Assessment | 4 | 1994 | 647 | 0.110 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.100 |
Why?
|
| Astrocytes | 1 | 1999 | 1273 | 0.100 |
Why?
|
| Personality Disorders | 5 | 1987 | 713 | 0.100 |
Why?
|
| Sertraline | 1 | 2011 | 206 | 0.090 |
Why?
|
| Music Therapy | 1 | 2011 | 102 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4749 | 0.090 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 1998 | 1443 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12066 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 1999 | 1411 | 0.080 |
Why?
|
| Meditation | 1 | 2011 | 240 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 3917 | 0.080 |
Why?
|
| Burns | 2 | 2011 | 1815 | 0.080 |
Why?
|
| Extinction, Psychological | 1 | 2011 | 376 | 0.080 |
Why?
|
| Ectoderm | 1 | 2008 | 137 | 0.080 |
Why?
|
| Microelectrodes | 1 | 2008 | 304 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2007 | 19 | 0.080 |
Why?
|
| Toxins, Biological | 1 | 2007 | 66 | 0.070 |
Why?
|
| Animals | 12 | 2012 | 168660 | 0.070 |
Why?
|
| Connexin 43 | 1 | 2008 | 207 | 0.070 |
Why?
|
| Gap Junctions | 1 | 2008 | 233 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 813 | 0.070 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 703 | 0.060 |
Why?
|
| Estrogens | 1 | 2011 | 1563 | 0.060 |
Why?
|
| Depression, Chemical | 1 | 2003 | 191 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2007 | 982 | 0.060 |
Why?
|
| Estradiol | 1 | 2011 | 2017 | 0.060 |
Why?
|
| Male | 16 | 2012 | 349776 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.060 |
Why?
|
| Amygdala | 1 | 2011 | 1313 | 0.060 |
Why?
|
| Microfluidics | 1 | 2008 | 662 | 0.060 |
Why?
|
| Psychometrics | 8 | 2004 | 3000 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2011 | 2483 | 0.050 |
Why?
|
| Fear | 1 | 2011 | 1438 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 8939 | 0.050 |
Why?
|
| Receptor, trkA | 1 | 2003 | 164 | 0.050 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2003 | 200 | 0.050 |
Why?
|
| Patient Readmission | 1 | 1996 | 3117 | 0.050 |
Why?
|
| Psychiatry | 2 | 2004 | 1694 | 0.050 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 1420 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 4320 | 0.050 |
Why?
|
| Coronary Disease | 1 | 1996 | 6078 | 0.050 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1176 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 964 | 0.050 |
Why?
|
| Cell Communication | 1 | 2008 | 1621 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2008 | 1358 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1295 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2091 | 0.050 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1895 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2003 | 959 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2007 | 2712 | 0.040 |
Why?
|
| Schizophrenia | 1 | 1998 | 6865 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2003 | 956 | 0.040 |
Why?
|
| Vacuoles | 1 | 1999 | 229 | 0.040 |
Why?
|
| Gliosis | 1 | 1999 | 245 | 0.040 |
Why?
|
| Mentors | 1 | 2004 | 631 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2003 | 1794 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8316 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4183 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2012 | 35409 | 0.040 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2004 | 1951 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2715 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2748 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 1999 | 595 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6487 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 6237 | 0.030 |
Why?
|
| Hospitalization | 1 | 1996 | 10259 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2004 | 1181 | 0.030 |
Why?
|
| Child | 4 | 2011 | 77637 | 0.030 |
Why?
|
| Peptides | 1 | 2007 | 4406 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 2003 | 1226 | 0.030 |
Why?
|
| Female | 13 | 2011 | 380020 | 0.030 |
Why?
|
| Neurites | 2 | 2008 | 388 | 0.030 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2011 | 4266 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2009 | 4245 | 0.030 |
Why?
|
| Adolescent | 5 | 2011 | 85729 | 0.030 |
Why?
|
| Humans | 19 | 2011 | 743811 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2003 | 1861 | 0.030 |
Why?
|
| Attitude of Health Personnel | 2 | 2004 | 3839 | 0.030 |
Why?
|
| Genotype | 1 | 2007 | 12944 | 0.030 |
Why?
|
| Reference Values | 1 | 1999 | 4974 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2007 | 14563 | 0.030 |
Why?
|
| Propionates | 1 | 2011 | 169 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9440 | 0.020 |
Why?
|
| Psychophysics | 1 | 2011 | 309 | 0.020 |
Why?
|
| Mutation | 2 | 2007 | 29777 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 5021 | 0.020 |
Why?
|
| Mice | 3 | 2008 | 81154 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 40964 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 575 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2008 | 235 | 0.020 |
Why?
|
| Aging | 1 | 2007 | 8655 | 0.020 |
Why?
|
| Conditioning, Classical | 1 | 2011 | 366 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 18027 | 0.020 |
Why?
|
| Mental Disorders | 2 | 2004 | 6593 | 0.020 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2008 | 126 | 0.020 |
Why?
|
| Phenols | 1 | 2011 | 496 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 2008 | 187 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9731 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 19894 | 0.020 |
Why?
|
| Forecasting | 1 | 1996 | 2950 | 0.020 |
Why?
|
| Mitochondria | 1 | 1999 | 3513 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2008 | 284 | 0.020 |
Why?
|
| Nitriles | 1 | 2011 | 953 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2003 | 7880 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2008 | 1342 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2008 | 1760 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2004 | 5787 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2003 | 48 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 57744 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2008 | 710 | 0.010 |
Why?
|
| Boston | 1 | 1996 | 9310 | 0.010 |
Why?
|
| PC12 Cells | 1 | 2003 | 331 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2003 | 119 | 0.010 |
Why?
|
| Adult | 7 | 2011 | 213889 | 0.010 |
Why?
|
| Health Care Costs | 1 | 1996 | 3207 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 2086 | 0.010 |
Why?
|
| Antibodies, Blocking | 1 | 2003 | 253 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2003 | 224 | 0.010 |
Why?
|
| Time Factors | 3 | 2011 | 40038 | 0.010 |
Why?
|
| Nerve Growth Factor | 1 | 2003 | 148 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1677 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3144 | 0.010 |
Why?
|
| Action Potentials | 1 | 2008 | 1804 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2011 | 6030 | 0.010 |
Why?
|
| Pyrazoles | 1 | 2011 | 1970 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 431 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 758 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 646 | 0.010 |
Why?
|
| Job Satisfaction | 1 | 2004 | 535 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 709 | 0.010 |
Why?
|
| Oxygen | 1 | 2011 | 4189 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 928 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 840 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2008 | 2506 | 0.010 |
Why?
|
| Focus Groups | 1 | 2004 | 1320 | 0.010 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2003 | 604 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2008 | 11478 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 15526 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12020 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2003 | 1142 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1546 | 0.010 |
Why?
|
| Acting Out | 2 | 1987 | 16 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2003 | 5179 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6311 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 3339 | 0.010 |
Why?
|
| Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39001 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3772 | 0.010 |
Why?
|
| Guideline Adherence | 1 | 2004 | 2265 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 15993 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5881 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 2850 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5973 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1996 | 53250 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2008 | 9648 | 0.010 |
Why?
|
| Curriculum | 1 | 2004 | 3603 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 10940 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 4552 | 0.010 |
Why?
|
| Neurons | 1 | 2008 | 9336 | 0.010 |
Why?
|
| Interpersonal Relations | 2 | 1987 | 1424 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7270 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 9718 | 0.000 |
Why?
|
| Paranoid Personality Disorder | 1 | 1985 | 8 | 0.000 |
Why?
|
| Manuals as Topic | 1 | 1986 | 98 | 0.000 |
Why?
|
| Aged | 2 | 1996 | 163178 | 0.000 |
Why?
|
| Young Adult | 1 | 2011 | 56392 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2008 | 23398 | 0.000 |
Why?
|
| Schizotypal Personality Disorder | 1 | 1985 | 288 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 213241 | 0.000 |
Why?
|
| Borderline Personality Disorder | 1 | 1985 | 737 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2004 | 63042 | 0.000 |
Why?
|